GlassScriptPhysician profile
Joseph Metcalf
NPI 1356332126
$587.11
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $543 · 2020: $44.44.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $169.19 | 2019-2020 | |
| Endologix LLC | $94.92 | 2019 | |
| Lemaitre Vascular, INC. | $86.28 | 2019 | |
| Janssen Pharmaceuticals, INC | $52.08 | 2019 | |
| Covidien LP | $49.34 | 2019-2020 | |
| Medtronic Vascular, INC. | $30.85 | 2019 | |
| Osiris Therapeutics INC. | $21.95 | 2019 | |
| Shire North American Group INC | $15.00 | 2019 | |
| Ethicon US, LLC | $14.44 | 2019 | |
| Z-Medica, LLC | $14.44 | 2019 | |
| Kci USA, INC. | $14.19 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $12.54 | 2019 | |
| W. L. Gore & Associates, INC. | $11.89 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Metcalf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.